ANI Pharmaceuticals | ANIP - Des Atouts

Prix De L'Action
78.37
Variation Quotidienne
0.01 0.01%
Mensuellement
8.59%
Annuel
14.04%
Q2 Prévisions
76.22




Des Atouts Changement Date
AbbVie USD 133.96B 62M 2025-12
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Assertio Holdings USD 319.77M 46M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Canopy Growth CAD 1.11B 36.35M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Perrigo USD 8.54B 1.55B 2025-12
Sun Pharmaceuticals INR 1.04T 116.06B 2025-09
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12